Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-related disease (COVID-19) is an infectious disease characterised by systemic inflammation, which might enhance baseline thrombotic risk, especially in hospitalised patients. Little is, however, known about predictors of thrombotic complications in patients with COVID-19.
A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-centre cohort
Ramirez, Giuseppe A;DE Lorenzo, Rebecca;Borio, Giorgia;Gallina, Gabriele;Farolfi, Federica;Cavallo, Ludovica;Pascali, Maria;Castellani, Jacopo;Alba, Ada C;Zangrillo, Alberto;Piemonti, Lorenzo;Rovere Querini, Patrizia;Landoni G
2022-01-01
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-related disease (COVID-19) is an infectious disease characterised by systemic inflammation, which might enhance baseline thrombotic risk, especially in hospitalised patients. Little is, however, known about predictors of thrombotic complications in patients with COVID-19.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
